We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+13.16%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$14.9B
AUM Growth
+$995M
Cap. Flow
-$291M
Cap. Flow %
-1.95%
Top 10 Hldgs %
26.38%
Holding
2,856
New
31
Increased
336
Reduced
1,500
Closed
71

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$28.4M
2
MSFT icon
Microsoft
MSFT
+$25.6M
3
NVDA icon
NVIDIA
NVDA
+$15.2M
4
AMZN icon
Amazon
AMZN
+$11.2M
5
IWM icon
iShares Russell 2000 ETF
IWM
+$10.9M

Sector Composition

Rank Sector Weight
1 Technology 27.53%
2 Financials 12.17%
3 Healthcare 11.68%
4 Consumer Discretionary 10.99%
5 Industrials 9.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HAL icon
276
Halliburton
HAL
$27.7B
$8.52M 0.06%
216,033
-8,745
-4% -$313K
FICO icon
277
Fair Isaac
FICO
$22.6B
$8.51M 0.06%
6,811
-180
-3% -$225K
PR
278
Permian Resources
PR
$18B
$8.42M 0.06%
476,730
+46,950
+11% +$689K
PPG icon
279
PPG Industries
PPG
$25.5B
$8.35M 0.06%
57,623
-2,021
-3% -$287K
PCG icon
280
PG&E
PCG
$38.3B
$8.34M 0.06%
497,666
-18,375
-4% -$308K
KMI icon
281
Kinder Morgan
KMI
$70.7B
$8.31M 0.06%
453,325
-16,652
-4% -$291K
FANG icon
282
Diamondback Energy
FANG
$56.2B
$8.3M 0.06%
41,895
-1,540
-4% -$261K
MRNA icon
283
Moderna
MRNA
$25.4B
$8.28M 0.06%
77,680
-2,857
-4% -$288K
ACGL icon
284
Arch Capital
ACGL
$33.2B
$8.2M 0.06%
88,689
-3,671
-4% -$310K
OC icon
285
Owens Corning
OC
$12.3B
$8.14M 0.05%
48,820
-1,287
-3% -$196K
GPN icon
286
Global Payments
GPN
$23.4B
$8.14M 0.05%
60,917
-2,241
-4% -$296K
FND icon
287
Floor & Decor
FND
$6.32B
$8.14M 0.05%
62,798
-1,530
-2% -$174K
BRBR icon
288
BellRing Brands
BRBR
$1.26B
$8.1M 0.05%
137,279
-3,102
-2% -$177K
ANSS
289
DELISTED
Ansys
ANSS
$8.09M 0.05%
23,307
-710
-3% -$240K
NBIX icon
290
Neurocrine Biosciences
NBIX
$15.9B
$8.08M 0.05%
58,604
-744
-1% -$102K
RCL icon
291
Royal Caribbean
RCL
$82.4B
$8.08M 0.05%
58,108
-1,982
-3% -$248K
WST icon
292
West Pharmaceutical
WST
$24.8B
$8.07M 0.05%
20,384
-626
-3% -$232K
RMD icon
293
ResMed
RMD
$32.8B
$8M 0.05%
40,402
-1,247
-3% -$228K
CHTR icon
294
Charter Communications
CHTR
$17.9B
$7.94M 0.05%
27,324
-1,246
-4% -$401K
AIT icon
295
Applied Industrial Technologies
AIT
$13B
$7.92M 0.05%
40,067
+19,824
+98% +$3.62M
MTD icon
296
Mettler-Toledo International
MTD
$28.8B
$7.87M 0.05%
5,913
-253
-4% -$312K
BKR icon
297
Baker Hughes
BKR
$63.8B
$7.85M 0.05%
234,303
-10,094
-4% -$311K
ADM icon
298
Archer Daniels Midland
ADM
$38.4B
$7.84M 0.05%
124,897
-4,592
-4% -$270K
UFPI icon
299
UFP Industries
UFPI
$5.06B
$7.82M 0.05%
63,539
-1,458
-2% -$169K
MTDR icon
300
Matador Resources
MTDR
$6.5B
$7.8M 0.05%
116,850
-3,135
-3% -$186K

Similar funds

MetLife Investment Management's Q1 2024 Portfolio in Review

As of Q1 2024, MetLife Investment Management held 2,856 positions worth $14.9B, up 7.2% from $13.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Trading was light in Q1 2024: portfolio turnover was 3.6%. MetLife Investment Management opened 31 new positions and exited 71, leaving the 2,856-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q1 2024 buy was Flutter Entertainment: 9,898 shares worth $1.98M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q1 2024, an estimated $128M increase.
  • MetLife Investment Management's biggest Q1 2024 reduction was Apple, cutting an estimated $28.4M.
  • MetLife Investment Management fully exited Immunogen Inc in Q1 2024, selling an estimated $3.72M.
  • MetLife Investment Management's ten largest holdings make up 26% of its $14.9B portfolio in Q1 2024.
  • MetLife Investment Management opened 31 new positions and closed 71 in Q1 2024.
  • MetLife Investment Management's portfolio value rose 7.2% quarter-over-quarter to $14.9B.

Based on MetLife Investment Management's 13F filing for Q1 2024, filed 14 May 2024.